Your browser doesn't support javascript.
loading
Tumor budding is an independent prognostic factor in stage III colon cancer patients: a post-hoc analysis of the IDEA-France phase III trial (PRODIGE-GERCOR).
Basile, D; Broudin, C; Emile, J F; Falcoz, A; Pagès, F; Mineur, L; Bennouna, J; Louvet, C; Artru, P; Fratte, S; Ghiringhelli, F; André, T; Derangère, V; Vernerey, D; Taieb, J; Svrcek, M.
Afiliação
  • Basile D; Department of Hepatogastroenterology and Gastrointestinal Oncology, University of Paris (Paris Descartes), SIRIC CARPEM, Georges Pompidou European Hospital, AP-HP, Paris, France; Department of Medicine, DAME, University Hospital of Udine, Udine, Italy; Department of Medical Oncology, ULSS8 Berica, V
  • Broudin C; Department of Pathology, Georges Pompidou European Hospital, AP-HP, Paris, France.
  • Emile JF; Department of Pathology, Ambroise Paré Hospital, AP-HP, Boulogne, France; SIRIC CARPEM, University of Paris, Paris, France; Research Unit EA4340 'Biomarkers and Clinical Trials in Oncology and Onco-Hematology', Versailles Saint-Quentin-en-Yvelines University, Boulogne, France.
  • Falcoz A; Methodology and Quality of Life Unit in Oncology, University Hospital of Besançon, Besançon, France; INSERM UMR1098, University of Bourgogne Franche-Comté, National Institute of Health and Research, Etablissement Français du Sang Bourgogne Franche-Comté, Besançon, France.
  • Pagès F; Department of Immunology, AP-HP, Hôpital Européen Georges Pompidou, University of Paris, Paris, France.
  • Mineur L; Department of Radiation Therapy, Institut Sainte Catherine, Avignon, France.
  • Bennouna J; Department of Medical Oncology, University Hospital of Nantes, Nantes, France.
  • Louvet C; Department of Medical Oncology, Institut Mutualiste Montsouris, Paris, France.
  • Artru P; Department of Medical Oncology, Jean Mermoz Private Hospital, Lyon, France.
  • Fratte S; Department of Medical Oncology, Belfort-Montbeliard Hospital, Montbeliard, France; Besançon Hospital, Besançon, France.
  • Ghiringhelli F; Platform of Transfer in Cancer Biology, Centre Georges François Leclerc, INSERM LNC UMR1231, University of Bourgogne Franche-Comté, Dijon, France.
  • André T; Department of Medical Oncology, Saint-Antoine Hospital, AP-HP, Paris, France; SIRIC CURAMUS, Sorbonne University, Paris, France.
  • Derangère V; Besançon Hospital, Besançon, France; Platform of Transfer in Cancer Biology, Centre Georges François Leclerc, INSERM LNC UMR1231, University of Bourgogne Franche-Comté, Dijon, France.
  • Vernerey D; Methodology and Quality of Life Unit in Oncology, University Hospital of Besançon, Besançon, France; INSERM UMR1098, University of Bourgogne Franche-Comté, National Institute of Health and Research, Etablissement Français du Sang Bourgogne Franche-Comté, Besançon, France.
  • Taieb J; Department of Hepatogastroenterology and Gastrointestinal Oncology, University of Paris (Paris Descartes), SIRIC CARPEM, Georges Pompidou European Hospital, AP-HP, Paris, France. Electronic address: jtaieb75@gmail.com.
  • Svrcek M; Department of Medical Oncology, Saint-Antoine Hospital, AP-HP, Paris, France; SIRIC CURAMUS, Sorbonne University, Paris, France. Electronic address: magali.svrcek@aphp.fr.
Ann Oncol ; 33(6): 628-637, 2022 06.
Article em En | MEDLINE | ID: mdl-35306156
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Colo Tipo de estudo: Prognostic_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Colo Tipo de estudo: Prognostic_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article